Latest Breaking News On - Otmane boussif - Page 1 : comparemela.com

Anjarium Biosciences appoints ex-Novartis gene therapy leader Otmane Boussif, DSc as Chief Technology Officer

ZURICH, Dec. 8, 2022 /PRNewswire/ Anjarium Biosciences AG ("Anjarium"), a biotech company focused on creating and delivering a new class of non-viral gene therapies, today announces the appointment

Eleanor perkinGeorge underwoodStephen yooAnjarium biosciencesOtmane boussifPrnewswire anjarium biosciencesKostenloser wertpapierhandelLouis pasteurGlobal head of early phase developmentChief technology officerGlobal headGene therapy technical developmentEarly phaseGene therapyInvestigational new drugApplied biological

Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the

United statesFrance generalInstitut pasteurMary jane elliott jessica hodgsonCatherine leveauOtmane boussifSensorion preclinical developmentPanel discussionInternational media relationsConsilium strategic communicationsRegulatory newsPreclinical development directorGene therapyGene therapy neurological disorders europeLaurent desireChief technical officer

Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium an

MONTPELLIER, France (BUSINESS WIRE) Regulatory News:Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation of member.

United statesFrance generalInstitut pasteurMary jane elliott jessica hodgsonCatherine leveauOtmane boussifSensorion preclinical developmentPanel discussionInternational media relationsConsilium strategic communicationsRegulatory newsPreclinical development directorGene therapyGene therapy neurological disorders europeLaurent desireGene therapy neurological disorders

Sensorion to Present at the Gene Therapy Development and Manufacturing Conference in June 2022

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the

United kingdomCity ofInstitut pasteurMary jane elliott jessica hodgsonCatherine leveauOtmane boussifGene therapy developmentInternational media relationsConsilium strategic communicationsRegulatory newsChief technical officerTherapy approach for hearing disordersCisplatin induced ototoxicityCochlear limitedInvestor relations communicationStrategic communications

Sensorion Appoints Ex-Novartis Cell Therapy & Viral Vectors Head Otmane Boussif as Chief Technical Officer

Sensorion Appoints Ex-Novartis Cell Therapy & Viral Vectors Head Otmane Boussif as Chief Technical Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Nawal ouzrenSanofi pasteurMarkus metzgerLouis pasteurSophie baumontOtmane boussifHead of investor relations corporate communicationsGlobal head of early phase developmentGene therapy technical developmentRegulatory newsChief technical officerGlobal headEarly phaseGene therapyInvestigational new drugFormulation processes